These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19662384)

  • 41. [Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram, in patients with major depressive disorder--the navigade switch study].
    Schmitt L; Arbus C; Tonnoir B
    Encephale; 2006; 32(2 Pt 1):270-7. PubMed ID: 16910629
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings.
    Musselman D; Royster EB; Wang M; Long Q; Trimble LM; Mann TK; Graciaa DS; McNutt MD; Auyeung NS; Oliver L; Lawson DH; Miller AH
    Neuropsychopharmacology; 2013 Sep; 38(10):1921-8. PubMed ID: 23575741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor, during lifespan in humans.
    Berardelli R; Margarito E; Ghiggia F; Picu A; Balbo M; Bonelli L; Giordano R; Karamouzis I; Bo M; Ghigo E; Arvat E
    J Endocrinol Invest; 2010 Oct; 33(9):657-62. PubMed ID: 20414043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of citalopram treatment on hypothermic and hormonal responses to the 5-HT1A receptor agonist buspirone in patients with major depression and therapeutic response.
    Navinés R; Martín-Santos R; Gómez-Gil E; Martínez de Osaba MJ; Imaz ML; Gastó C
    Psychoneuroendocrinology; 2007 May; 32(4):411-6. PubMed ID: 17337123
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Escitalopram: a second-generation SSRI.
    Owens MJ; Rosenbaum JF
    CNS Spectr; 2002 Apr; 7(4 Suppl 1):34-9. PubMed ID: 15131491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Citalopram challenge in social anxiety disorder.
    Shlik J; Maron E; Tru I; Aluoja A; Vasar V
    Int J Neuropsychopharmacol; 2004 Jun; 7(2):177-82. PubMed ID: 14741063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The allosteric citalopram binding site differentially interferes with neuronal firing rate and SERT trafficking in serotonergic neurons.
    Matthäus F; Haddjeri N; Sánchez C; Martí Y; Bahri S; Rovera R; Schloss P; Lau T
    Eur Neuropsychopharmacol; 2016 Nov; 26(11):1806-1817. PubMed ID: 27665061
    [TBL] [Abstract][Full Text] [Related]  

  • 48. R-citalopram attenuates anxiolytic effects of escitalopram in a rat ultrasonic vocalisation model.
    Sánchez C
    Eur J Pharmacol; 2003 Mar; 464(2-3):155-8. PubMed ID: 12620508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The pharmacokinetics of escitalopram after oral and intravenous administration of single and multiple doses to healthy subjects.
    Søgaard B; Mengel H; Rao N; Larsen F
    J Clin Pharmacol; 2005 Dec; 45(12):1400-6. PubMed ID: 16291715
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroendocrine effects of a 20-mg citalopram infusion in healthy males. A placebo-controlled evaluation of citalopram as 5-HT function probe.
    Seifritz E; Baumann P; Müller MJ; Annen O; Amey M; Hemmeter U; Hatzinger M; Chardon F; Holsboer-Trachsler E
    Neuropsychopharmacology; 1996 Apr; 14(4):253-63. PubMed ID: 8924193
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Escitalopram, but not its major metabolites, exhibits antiplatelet activity in humans.
    Atar D; Malinin A; Takserman A; Pokov A; van Zyl L; Tanguay JF; Lesperance F; Serebruany V
    J Clin Psychopharmacol; 2006 Apr; 26(2):172-7. PubMed ID: 16633147
    [TBL] [Abstract][Full Text] [Related]  

  • 52. S-Citalopram in neuroendocrine challenge-tests: serotonergic responsivity in healthy male and female human participants.
    Kuepper Y; Bausch S; Iffland J; Reuter M; Hennig J
    Psychoneuroendocrinology; 2006 Nov; 31(10):1200-7. PubMed ID: 17123742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of a selective serotonin reuptake inhibitor escitalopram on the cutaneous silent period: a randomized controlled study in healthy volunteers.
    Pujia F; Serrao M; Brienza M; Vestrini E; Valente GO; Coppola G; Pierelli F
    Neurosci Lett; 2014 Apr; 566():17-20. PubMed ID: 24589881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of citalopram and environmental temperature on exercise-induced changes in BDNF.
    Goekint M; Roelands B; Heyman E; Njemini R; Meeusen R
    Neurosci Lett; 2011 Apr; 494(2):150-4. PubMed ID: 21385602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The metabolic syndrome is associated with reduced central serotonergic responsivity in healthy community volunteers.
    Muldoon MF; Mackey RH; Korytkowski MT; Flory JD; Pollock BG; Manuck SB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):718-21. PubMed ID: 16303834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serotonin modulation of cerebral glucose metabolism in normal aging.
    Goldberg S; Smith GS; Barnes A; Ma Y; Kramer E; Robeson K; Kirshner M; Pollock BG; Eidelberg D
    Neurobiol Aging; 2004 Feb; 25(2):167-74. PubMed ID: 14749134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concentrations of citalopram and escitalopram in postmortem hair segments.
    Rygaard K; Nielsen MKK; Linnet K; Banner J; Johansen SS
    Forensic Sci Int; 2022 Jul; 336():111349. PubMed ID: 35660811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of escitalopram on vagally mediated cardiovascular function in healthy participants: implications for understanding differential age-related, treatment emergent effects.
    Kemp AH; Outhred T; Saunders S; Brunoni AR; Nathan PJ; Malhi GS
    Psychopharmacology (Berl); 2014 Jun; 231(11):2281-90. PubMed ID: 24337078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Addictive and nonaddictive smoking as related to responsivity to neurotransmitter systems.
    Netter P; Toll C; Lujic C; Reuter M; Hennig J
    Behav Pharmacol; 2002 Sep; 13(5-6):441-9. PubMed ID: 12394420
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantification of cerebral blood flow as biomarker of drug effect: arterial spin labeling phMRI after a single dose of oral citalopram.
    Chen Y; Wan HI; O'Reardon JP; Wang DJ; Wang Z; Korczykowski M; Detre JA
    Clin Pharmacol Ther; 2011 Feb; 89(2):251-8. PubMed ID: 21191380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.